{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:30:12Z","timestamp":1792218612346,"version":"4.4.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03315-0","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:47:25Z","timestamp":1767977245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Admixture Compatibility Studies in Parenteral Formulations: Packaging, Device, and Regulatory Perspectives"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7093-5061","authenticated-orcid":false,"given":"Chetana","family":"Eknure","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3744-1507","authenticated-orcid":false,"given":"Vishvesh","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4197-3701","authenticated-orcid":false,"given":"Yogeshwar","family":"Bachhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"3315_CR1","unstructured":"Rutuja Giram DB, AKAN,. A Comprehensive Review on Parenterals. International Journal of Pharmaceutical Sciences [Internet]. IJPS Journal; 2024 [cited 2025 Sep 11];02:2318\u201336. 10.5281\/ZENODO.14505464"},{"issue":"1","key":"3315_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.33545\/26646862.2025.V7.I1E.136","volume":"7","author":"M Badhan","year":"2025","unstructured":"Badhan M, verma P, Singh AP, Singh AP, Prime Publications. Advancements in parenteral preparation techniques: a review article. International Journal of Pharmaceutical Research and Development [Internet]. 2025;7(1):411\u20135. https:\/\/doi.org\/10.33545\/26646862.2025.V7.I1E.136.","journal-title":"International Journal of Pharmaceutical Research and Development [Internet]"},{"issue":"2","key":"3315_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/JPEN.2306","volume":"46","author":"JI Boullata","year":"2022","unstructured":"Boullata JI, Mirtallo JM, Sacks GS, Salman G, Gura K, Canada T, et al. Parenteral nutrition compatibility and stability: a comprehensive review. J Parenter Enteral Nutr. 2022;46(2):273\u201399. https:\/\/doi.org\/10.1002\/JPEN.2306.","journal-title":"J Parenter Enteral Nutr"},{"key":"3315_CR4","doi-asserted-by":"publisher","unstructured":"Piggott T, Moja L, Huttner B, Okwen P, Raviglione MCB, Kredo T, et al. WHO Model List of Essential Medicines: visions for the future. Bull World Health Organ [Internet]. World Health Organization; 2024 [cited 2025 Sep 11];102:722\u20139. https:\/\/doi.org\/10.2471\/BLT.24.292359","DOI":"10.2471\/BLT.24.292359"},{"key":"3315_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/J.JDDST.2024.106089","author":"S Kumar","year":"2024","unstructured":"Kumar S, Sanap SN, Vasoya M, Handa M, Pandey P, Khopade A, et al. Application of lyophilization in pharmaceutical injectable formulations: an industry and regulatory perspective. J Drug Deliv Sci Technol. 2024. https:\/\/doi.org\/10.1016\/J.JDDST.2024.106089.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3315_CR6","unstructured":"Matt Bourassa. The Art and Science of Lyophilization in Biologic Drug Development - PCI Services [Internet]. 2025 [cited 2025 Sep 3]. https:\/\/pci.com\/resources\/lyophilization-biologic-drug-development\/. Accessed 3 Sep 2025"},{"key":"3315_CR7","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/S11095-025-03869-5\/FIGURES\/1","volume":"42","author":"A Alexeenko","year":"2025","unstructured":"Alexeenko A, Korang-Yeboah M, Tchessalov S. Critical needs and opportunities for advanced manufacturing of lyophilized injectables. Pharm Res. 2025;42:1059\u201364. https:\/\/doi.org\/10.1007\/S11095-025-03869-5\/FIGURES\/1.","journal-title":"Pharm Res"},{"key":"3315_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","volume":"203","author":"W Wang","year":"2000","unstructured":"Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203:1\u201360. https:\/\/doi.org\/10.1016\/S0378-5173(00)00423-3.","journal-title":"Int J Pharm"},{"issue":"1","key":"3315_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ABT\/TBAD031","volume":"7","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhou N, Yang C, Jin Z, Guo J. Multiple approaches to reduce reconstitution time of lyophilized drug products with high protein concentration. Antibody Ther. 2024;7(1):67\u201376. https:\/\/doi.org\/10.1093\/ABT\/TBAD031.","journal-title":"Antibody Ther"},{"key":"3315_CR10","doi-asserted-by":"publisher","unstructured":"Sharma M, Cheung JK, Dabbara A, Petersen J. Intravenous Admixture Compatibility for Sterile Products: Challenges and Regulatory Guidance. Springer, New York, NY; 2013 [cited 2025 Sep 11];461\u201374. https:\/\/doi.org\/10.1007\/978-1-4614-7978-9_17","DOI":"10.1007\/978-1-4614-7978-9_17"},{"key":"3315_CR11","unstructured":"S. Sriram, S. Aishwarya, A. Ajith Kumar, Akshaya Sebastian, Akhila Moithu. Intravenous drug incompatibility in intensive care units - A comprehensive review [Internet]. 2018 [cited 2025 Sep 3]. http:\/\/innpharmacotherapy.com\/VolumeArticles\/FullTextPDF\/10182_04_IPP-06-JS-2018-17_SRI.pdf. Accessed 3 Sep 2025"},{"key":"3315_CR12","doi-asserted-by":"publisher","unstructured":"Tomczak S, Gosty\u00b4nska A, Gosty\u00b4nska G, Nadolna M, Reisner K, Orlando M, et al. antibiotics Stability and Compatibility Aspects of Drugs: The Case of Selected Cephalosporins. 2021 [cited 2025 Sep 3]; https:\/\/doi.org\/10.3390\/antibiotics10050549","DOI":"10.3390\/antibiotics10050549"},{"issue":"2","key":"3315_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/J.MEDINE.2018.08.008","volume":"44","author":"G Castells Lao","year":"2020","unstructured":"Castells Lao G, Rodr\u00edguez Reyes M, Roura Turet J, Prat Dot M, Soy Muner D, L\u00f3pez Cabezas C. Compatibility of drugs administered as Y-site infusion in intensive care units: a systematic review. Medicina Intensiva (English Edition). 2020;44(2):80\u20137. https:\/\/doi.org\/10.1016\/J.MEDINE.2018.08.008.","journal-title":"Medicina Intensiva (English Edition)"},{"key":"3315_CR14","doi-asserted-by":"publisher","unstructured":"Noby N, Gayathiri G, Vijayakumar A. Incompatibility of Intravenous Drugs. IOSR Journal Of Pharmacy And Biological Sciences (IOSR-JPBS [Internet]. [cited 2025 Sep 11];15:1\u201302. https:\/\/doi.org\/10.9790\/3008-1505040102","DOI":"10.9790\/3008-1505040102"},{"key":"3315_CR15","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1097\/CCM.0B013E3181E8ADCC","volume":"38","author":"S Kanji","year":"2010","unstructured":"Kanji S, Lam J, Johanson C, Singh A, Goddard R, Fairbairn J, et al. <article-title update=\"added\">Systematic review of physical and chemical compatibility of commonly used medications administered by continuous infusion in intensive care units: Crit Care Med. 2010;38:1890\u20138. https:\/\/doi.org\/10.1097\/CCM.0B013E3181E8ADCC.","journal-title":"Crit Care Med"},{"key":"3315_CR16","doi-asserted-by":"publisher","unstructured":"Full article: Drug stability testing and formulation strategies [Internet]. [cited 2025 Sep 26]. https:\/\/www.tandfonline.com\/doi\/full\/https:\/\/doi.org\/10.1080\/10837450.2018.1548742. Accessed 26 Sep 2025","DOI":"10.1080\/10837450.2018.1548742"},{"key":"3315_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2146\/AJHP080059","volume":"66","author":"DW Newton","year":"2009","unstructured":"Newton DW. Drug incompatibility chemistry. Am J Health-Syst Pharm. 2009;66:348\u201357. https:\/\/doi.org\/10.2146\/AJHP080059.","journal-title":"Am J Health-Syst Pharm"},{"key":"3315_CR18","unstructured":"Malarvizhi P, S AK, Binu AS, Professor A, Pharm VD. An Insight to Intravenous Drug Incompatibilities For Better Patient Care. International Journal for Research Trends and Innovation (www.ijrti.org) [Internet]. 2022 [cited 2025 Sep 11];7:489. www.ijrti.org. Accessed 11 Sep 2025"},{"key":"3315_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3390\/PHARMACEUTICS16020264","volume":"16","author":"D Kirby","year":"2024","unstructured":"Kirby D, Iacobazzi RM, Gosty\u00b4nska A, Gosty\u00b4nska G, Przybylski T, Ogrodowczyk M. Y-site compatibility studies of parenteral nutrition and other intravenous medications in neonatal and pediatric patients: a review of the literature evidence. Pharmaceutics. 2024;16:264. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16020264.","journal-title":"Pharmaceutics"},{"key":"3315_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/415310","author":"M Stawny","year":"2013","unstructured":"Stawny M, Olijarczyk R, Jaroszkiewicz E, Jeli\u0144ska A, ScientificWorld Ltd. Pharmaceutical point of view on parenteral nutrition. Sci World J. 2013. https:\/\/doi.org\/10.1155\/2013\/415310.","journal-title":"Sci World J"},{"key":"3315_CR21","doi-asserted-by":"publisher","first-page":"E1660","DOI":"10.1097\/PTS.0000000000000632","volume":"17","author":"S Kuitunen","year":"2021","unstructured":"Kuitunen S, Niittynen I, Airaksinen M, Holmstr\u00f6m AR, Lippincott Williams and Wilkins. Systemic causes of in-hospital intravenous medication errors: a systematic review. J Patient Saf. 2021;17:E1660\u20138. https:\/\/doi.org\/10.1097\/PTS.0000000000000632.","journal-title":"J Patient Saf"},{"key":"3315_CR22","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1016\/J.CLNME.2013.06.001","volume":"8","author":"D Cardona","year":"2013","unstructured":"Cardona D, Nadal M, Estelrich J, Mangues MA. Review of drug stability in parenteral nutrition admixtures. ESPEN J. 2013;8:e135-40. https:\/\/doi.org\/10.1016\/J.CLNME.2013.06.001.","journal-title":"ESPEN J"},{"key":"3315_CR23","doi-asserted-by":"publisher","unstructured":"Hartman C, Shamir R, Simchowitz V, Lohner S, Cai W, Decsi T, Churchill Livingstone, et al. ESPGHAN\/ESPEN\/ESPR\/CSPEN guidelines on pediatric parenteral nutrition: complications. Clin Nutr. 2018;37:2418\u201329. https:\/\/doi.org\/10.1016\/j.clnu.2018.06.956.","DOI":"10.1016\/j.clnu.2018.06.956"},{"issue":"6","key":"3315_CR24","doi-asserted-by":"publisher","first-page":"506","DOI":"10.5731\/PDAJPST.2020.012617","volume":"75","author":"D Jenke","year":"2021","unstructured":"Jenke D. A safety risk-based extractables and\/or leachables qualification strategy for packaged drug products. PDA J Pharm Sci Technol. 2021;75(6):506\u201335. https:\/\/doi.org\/10.5731\/PDAJPST.2020.012617.","journal-title":"PDA J Pharm Sci Technol"},{"key":"3315_CR25","doi-asserted-by":"publisher","unstructured":"Brown H, Mahler HC, Mellman J, Nieto A, Wagner D, Schaar M, PDA J Pharm Sci Technol, et al. Container closure integrity testing-practical aspects and approaches in the pharmaceutical industry. PDA J Pharm Sci Technol. 2017;71(2):147\u201362. https:\/\/doi.org\/10.5731\/PDAJPST.2016.006999.","DOI":"10.5731\/PDAJPST.2016.006999"},{"key":"3315_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/J.EJPB.2023.04.002","volume":"187","author":"M Farhan","year":"2023","unstructured":"Farhan M, McCallion N, Bennett J, Cram A, O\u2019Brien F. Stability and compatibility of parenteral nutrition solutions; a review of influencing factors. Eur J Pharm Biopharm. 2023;187:87\u201395. https:\/\/doi.org\/10.1016\/J.EJPB.2023.04.002.","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"3315_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/S00228-018-2602-6","volume":"75","author":"O Maison","year":"2019","unstructured":"Maison O, Tardy C, Cabelguenne D, Parat S, Ducastelle S, Piriou V, et al. Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units. Eur J Clin Pharmacol. 2019;75(2):179\u201387. https:\/\/doi.org\/10.1007\/S00228-018-2602-6.","journal-title":"Eur J Clin Pharmacol"},{"key":"3315_CR28","unstructured":"Evaluating, Reporting on Pharmaceutical IV Stability, Compatibility [Internet]. [cited 2025 Sep 26]. https:\/\/www.uspharmacist.com\/article\/evaluating-reporting-on-pharmaceutical-iv-stability-compatibility. Accessed 26 Sep 2025"},{"key":"3315_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2023.1265945\/BIBTEX","volume":"14","author":"CY Zhu","year":"2023","unstructured":"Zhu CY, Zuo HY, Li HL, Tong RS. Drug compatibility with various closed intravenous infusion containers. Front Pharmacol. 2023;14. https:\/\/doi.org\/10.3389\/FPHAR.2023.1265945\/BIBTEX.","journal-title":"Front Pharmacol"},{"key":"3315_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2146\/ajhp070138","volume":"65","author":"DW Newton","year":"2008","unstructured":"Newton DW, Driscoll DF. Calcium and phosphates Calcium and phosphate compatibility: revisited again. Am J Health-Syst Pharm. 2008;65:73\u201380. https:\/\/doi.org\/10.2146\/ajhp070138.","journal-title":"Am J Health-Syst Pharm"},{"key":"3315_CR31","doi-asserted-by":"publisher","unstructured":"Jahn M. Leachables and Extractables: From Regulatory Expectations to Laboratory Assessment. AAPS Advances in the Pharmaceutical Sciences Series [Internet]. Springer, Cham; 2018 [cited 2025 Sep 11];38:337\u201351. https:\/\/doi.org\/10.1007\/978-3-319-90603-4_16","DOI":"10.1007\/978-3-319-90603-4_16"},{"key":"3315_CR32","doi-asserted-by":"publisher","unstructured":"Guazzo D. Plastic packaging for parenteral drug delivery. Pharmaceutical Dosage Forms - Parenteral Medications [Internet]. CRC Press; 2016 [cited 2025 Aug 25];319\u201337. https:\/\/doi.org\/10.3109\/9781420086447-15","DOI":"10.3109\/9781420086447-15"},{"key":"3315_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0975-7406.111820","volume":"5","author":"N Zadbuke","year":"2013","unstructured":"Zadbuke N, Shahi S, Gulecha B, Padalkar A, Thube M. Recent trends and future of pharmaceutical packaging technology. J Pharm Bioallied Sci. 2013;5:98\u2013110. https:\/\/doi.org\/10.4103\/0975-7406.111820.","journal-title":"J Pharm Bioallied Sci"},{"key":"3315_CR34","unstructured":"Guidance for Industry Container Closure Systems for Packaging Human Drugs and Biologics CHEMISTRY, MANUFACTURING, AND CONTROLS DOCUMENTATION. Tel; 1999 [cited 2025 Sep 12];20857:301\u2013827. http:\/\/www.fda.gov\/cder\/guidance\/index.htmorhttp:\/\/www.fda.gov\/cber\/guidelines.htm. Accessed 12 Sep 2025"},{"key":"3315_CR35","doi-asserted-by":"publisher","unstructured":"Mathaes R, Streubel A. Parenteral Container Closure Systems. AAPS Advances in the Pharmaceutical Sciences Series [Internet]. Springer, Cham; 2018 [cited 2025 Sep 26];38:191\u2013202. https:\/\/doi.org\/10.1007\/978-3-319-90603-4_8","DOI":"10.1007\/978-3-319-90603-4_8"},{"key":"3315_CR36","unstructured":"Forcinio H. Selecting Primary Packaging for Parenterals [Internet]. MJH Life Sciences; 2018 [cited 2025 Sep 11]. p. 46\u201350\u201346\u201350. https:\/\/www.pharmtech.com\/view\/selecting-primary-packaging-parenterals. Accessed 11 Sep 2025"},{"key":"3315_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5731\/PDAJPST.2016.007377","volume":"71","author":"RA Schaut","year":"2017","unstructured":"Schaut RA, Weeks WP. Historical review of glasses used for parenteral packaging. PDA J Pharm Sci Technol. 2017;71:279\u201396. https:\/\/doi.org\/10.5731\/PDAJPST.2016.007377.","journal-title":"PDA J Pharm Sci Technol"},{"issue":"2","key":"3315_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5731\/PDAJPST.2012.00853","volume":"66","author":"E Guadagnino","year":"2012","unstructured":"Guadagnino E, Zuccato D. Delamination propensity of pharmaceutical glass containers by accelerated testing with different extraction media. PDA J Pharm Sci Technol. 2012;66(2):116\u201325. https:\/\/doi.org\/10.5731\/PDAJPST.2012.00853.","journal-title":"PDA J Pharm Sci Technol"},{"key":"3315_CR39","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5731\/PDAJPST.2013.00925","volume":"67","author":"G Jiang","year":"2013","unstructured":"Jiang G, Goss M, Li G, Jing W, Shen H, Fujimori K, et al. Novel mechanism of glass delamination in Type 1A borosilicate vials containing frozen protein formulations. PDA J Pharm Sci Technol. 2013;67:323\u201335. https:\/\/doi.org\/10.5731\/PDAJPST.2013.00925.","journal-title":"PDA J Pharm Sci Technol"},{"key":"3315_CR40","unstructured":"Recent Developments in Prefilled Syringes | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology [Internet]. [cited 2025 Sep 11]. https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/122329-Recent-Developments-in-Prefilled-Syringes\/. Accessed 11 Sep 2025"},{"key":"3315_CR41","unstructured":"Yasser Nashed- Samuel, Dengfeng Liu, Kiyoshi Fujimori, Lourdes Perez, Hans Lee PhD. Extractable and Leachable Implications on Biological Products in Prefilled Syringes | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology [Internet]. 2011 [cited 2025 Sep 3]. https:\/\/www.americanpharmaceuticalreview.com\/Featured-Articles\/37011-Extractable-and-Leachable-Implications-on-Biological-Products-in-Prefilled-Syringes\/. Accessed 3 Sep 2025"},{"key":"3315_CR42","doi-asserted-by":"publisher","unstructured":"Go\u00fbt TL, Misra S, Tipper ET, Bohlin MS, Guo R, Farnan I. ARTICLE Diffusive processes in aqueous glass dissolution. [cited 2025 Sep 11]; https:\/\/doi.org\/10.1038\/s41529-019-0102-5","DOI":"10.1038\/s41529-019-0102-5"},{"key":"3315_CR43","doi-asserted-by":"publisher","unstructured":"Akers MJ. Sterile Drug Products\u202f: Formulation, Packaging, Manufacturing and Quality. Sterile Drug Products [Internet]. CRC Press; 2016 [cited 2025 Sep 11]; https:\/\/doi.org\/10.3109\/9781420020564","DOI":"10.3109\/9781420020564"},{"key":"3315_CR44","unstructured":"9624 Guideline for plastic packaging system and components for pharmaceutical packaging. 2024;"},{"key":"3315_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/10837450903511178","volume":"15","author":"GA Sacha","year":"2010","unstructured":"Sacha GA, Saffell-Clemmer W, Abram K, Akers MJ. Practical fundamentals of glass, rubber, and plastic sterile packaging systems. Pharm Dev Technol. 2010;15:6\u201334. https:\/\/doi.org\/10.3109\/10837450903511178.","journal-title":"Pharm Dev Technol"},{"key":"3315_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2193-1801-3-58\/TABLES\/5","volume":"3","author":"H Luo","year":"2014","unstructured":"Luo H, Sun G, Shi Y, Shen Y, Xu K, SpringerOpen. Evaluation of the Di(2-ethylhexyl)phthalate released from polyvinyl chloride medical devices that contact blood. Springerplus. 2014;3:1\u20138. https:\/\/doi.org\/10.1186\/2193-1801-3-58\/TABLES\/5.","journal-title":"Springerplus"},{"key":"3315_CR47","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1517\/17425247.2014.928281","volume":"11","author":"DR Jenke","year":"2014","unstructured":"Jenke DR, Informa Healthcare. Extractables and leachables considerations for prefilled syringes. Expert Opin Drug Deliv. 2014;11:1591\u2013600. https:\/\/doi.org\/10.1517\/17425247.2014.928281.","journal-title":"Expert Opin Drug Deliv"},{"key":"3315_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/01.NAJ.0001108300.94648.AA","volume":"125","author":"DS Aschenbrenner","year":"2025","unstructured":"Aschenbrenner DS. ISMP warns of risk of injury with prefilled syringes packaged without needle safety guards. Am J Nurs. 2025;125:19. https:\/\/doi.org\/10.1097\/01.NAJ.0001108300.94648.AA.","journal-title":"Am J Nurs"},{"key":"3315_CR49","unstructured":"Liu W, Swift R, Torraca G, Nashed-Samuel Y, Wen Z-Q, Jiang Y, et al. Root Cause Analysis of Tungsten-Induced Protein Aggregation in Pre-filled Syringes. PDA J Pharm Sci Technol. 2010;64."},{"key":"3315_CR50","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1002\/JPS.21778","volume":"98","author":"Y Jiang","year":"2009","unstructured":"Jiang Y, Nashed-Samuel Y, Li C, Liu W, Pollastrini J, Mallard D, et al. Tungsten-induced protein aggregation: solution behavior. J Pharm Sci. 2009;98:4695\u2013710. https:\/\/doi.org\/10.1002\/JPS.21778.","journal-title":"J Pharm Sci"},{"key":"3315_CR51","unstructured":"Gabrielle Gehron. Rubber\u2019s Crucial Role: Enhancing Drug Delivery Device Functionality [Internet]. 2024 [cited 2025 Sep 3]. https:\/\/healthcare.datwyler.com\/blog\/perfecting-the-pharmaceutical-packaging-selection-process\/rubbers-crucial-role-enhancing-drug-delivery-device-functionality. Accessed 3 Sep 2025"},{"issue":"5","key":"3315_CR52","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1517\/14740338.6.5.487","volume":"6","author":"I Markovic","year":"2007","unstructured":"Markovic I. Evaluation of safety and quality impact of extractable and leachable substances in therapeutic biologic protein products: a risk-based perspective. Expert Opin Drug Saf. 2007;6(5):487\u201391. https:\/\/doi.org\/10.1517\/14740338.6.5.487.","journal-title":"Expert Opin Drug Saf"},{"issue":"5","key":"3315_CR53","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/jps.24387","volume":"104","author":"A Gerhardt","year":"2015","unstructured":"Gerhardt A, Nguyen BH, Lewus R, Carpenter JF, Randolph TW, John Wiley and Sons Inc. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes. J Pharm Sci. 2015;104(5):1601\u20139. https:\/\/doi.org\/10.1002\/jps.24387.","journal-title":"J Pharm Sci"},{"key":"3315_CR54","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1002\/JPS.21719","volume":"98","author":"R Thirumangalathu","year":"2009","unstructured":"Thirumangalathu R, Krishnan S, Ricci MS, Brems DN, Randolph TW, Carpenter JF, John Wiley and Sons Inc. Silicone oil- and agitation-induced aggregation of a monoclonal antibody in aqueous solution. J Pharm Sci. 2009;98:3167\u201381. https:\/\/doi.org\/10.1002\/JPS.21719.","journal-title":"J Pharm Sci"},{"key":"3315_CR55","unstructured":"Advancing extractables and leachables testing [Internet]. [cited 2025 Sep 26]. https:\/\/www.europeanpharmaceuticalreview.com\/article\/170814\/advancing-extractables-and-leachables-testing\/. Accessed 26 Sep 2025"},{"key":"3315_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2023.1115229","author":"F Zeng","year":"2023","unstructured":"Zeng F, Zhang L, Deng F, Lou S. Early-life exposure to di (2-ethyl-hexyl) phthalate: role in children with endocrine disorders. Front Cell Dev Biol. 2023. https:\/\/doi.org\/10.3389\/FCELL.2023.1115229.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"3315_CR57","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1167\/IOVS.10-6431","volume":"52","author":"L Liu","year":"2011","unstructured":"Liu L, Ammar DA, Ross LA, Mandava N, Kahook MY, Carpenter JF. Silicone oil microdroplets and protein aggregates in repackaged bevacizumab and ranibizumab: effects of long-term storage and product mishandling. Invest Ophthalmol Vis Sci. 2011;52(2):1023\u201334. https:\/\/doi.org\/10.1167\/IOVS.10-6431.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3315_CR58","unstructured":"Pharmaceutical glass interactions: A review of possibilities | Request PDF [Internet]. [cited 2025 Sep 16]. https:\/\/www.researchgate.net\/publication\/298641924_Pharmaceutical_glass_interactions_A_review_of_possibilities. Accessed 16 Sep 2025"},{"key":"3315_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2020.119332","author":"L Cuadros-Rodr\u00edguez","year":"2020","unstructured":"Cuadros-Rodr\u00edguez L, Laz\u00faen-Muros M, Ruiz-Sambl\u00e1s C, Navas-Iglesias N. Leachables from plastic materials in contact with drugs. State of the art and review of current analytical approaches. Int J Pharm. 2020. https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119332.","journal-title":"Int J Pharm"},{"key":"3315_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/SAFETY11030069","volume":"11","author":"Y Lv","year":"2025","unstructured":"Lv Y, Liu N, Chen C, Cai Z, Li J, Multidisciplinary Digital Publishing Institute. Pharmaceutical packaging materials and medication safety: a mini-review. Safety. 2025;11:69. https:\/\/doi.org\/10.3390\/SAFETY11030069.","journal-title":"Safety"},{"key":"3315_CR61","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1517\/17425247.2014.923400","volume":"11","author":"RG Ingle","year":"2014","unstructured":"Ingle RG, Agarwal AS. Pre-filled syringe-a ready-to-use drug delivery system: a review. Expert Opin Drug Deliv. 2014;11:1391\u20139. https:\/\/doi.org\/10.1517\/17425247.2014.923400.","journal-title":"Expert Opin Drug Deliv"},{"key":"3315_CR62","unstructured":"D2FTM Pre-Fillable Glass Syringe System - Silicone Oil-Free | Nipro Pre-fillable Glass Syringe Pharmaceutical Packaging [Internet]. [cited 2025 Sep 11]. https:\/\/www.nipro-group.com\/en\/our-offer\/products-services\/d2f-pre-fillable-glass-syringe-system-silicone-oil-free. Accessed 11 Sep 2025"},{"key":"3315_CR63","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1038\/S41433-020-0800-9","volume":"34","author":"CdeS Dias J\u00fanior","year":"2020","unstructured":"Dias J\u00fanior CdeS, Cardoso AL, Figueiredo AGdeA, Ota S, Melo GB. Agitation of the syringe and release of silicone oil. Eye. 2020;34:2242\u20138. https:\/\/doi.org\/10.1038\/S41433-020-0800-9.","journal-title":"Eye"},{"key":"3315_CR64","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/J.IJPHARM.2017.01.015","volume":"519","author":"M Shah","year":"2017","unstructured":"Shah M, Rattray Z, Day K, Uddin S, Curtis R, van der Walle CF, et al. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: an orthogonal study characterising the entire subvisible size range. Int J Pharm. 2017;519:58\u201366. https:\/\/doi.org\/10.1016\/J.IJPHARM.2017.01.015.","journal-title":"Int J Pharm"},{"key":"3315_CR65","doi-asserted-by":"publisher","unstructured":"Zhao X, Chen Y, Hamzaoui H, Wen X, Song J, Wang K, et al. Glass Silicone Oil Free Pre-filled Syringe as Primary Container in Autoinjector. Pharm Res [Internet]. Springer; 2024 [cited 2025 Sep 3];41:2319\u201329. https:\/\/doi.org\/10.1007\/S11095-024-03795-Y\/METRICS","DOI":"10.1007\/S11095-024-03795-Y\/METRICS"},{"issue":"4","key":"3315_CR66","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/2230-973X.93004","volume":"1","author":"B Basu","year":"2011","unstructured":"Basu B, Dharamsi A, Makwana S, Makasana Y. Prefilled syringes: an innovation in parenteral packaging. Int J Pharm Pharm Sci. 2011;1(4):200. https:\/\/doi.org\/10.4103\/2230-973X.93004.","journal-title":"Int J Pharm Pharm Sci"},{"issue":"5","key":"3315_CR67","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.xphs.2016.02.019","volume":"105","author":"CF Chisholm","year":"2016","unstructured":"Chisholm CF, Baker AE, Soucie KR, Torres RM, Carpenter JF, Randolph TW. Silicone oil microdroplets can induce antibody responses against recombinant murine growth hormone in mice. J Pharm Sci. 2016;105(5):1623\u201332. https:\/\/doi.org\/10.1016\/j.xphs.2016.02.019.","journal-title":"J Pharm Sci"},{"issue":"2","key":"3315_CR68","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5731\/PDAJPST.2012.00856","volume":"66","author":"E Chan","year":"2012","unstructured":"Chan E, Hubbard A, Sane S, Maa YF, Parenteral Drug Association (PDA). Syringe siliconization process investigation and optimization. PDA J Pharm Sci Technol. 2012;66(2):136\u201350. https:\/\/doi.org\/10.5731\/PDAJPST.2012.00856.","journal-title":"PDA J Pharm Sci Technol"},{"issue":"6","key":"3315_CR69","doi-asserted-by":"publisher","first-page":"572","DOI":"10.5731\/PDAJPST.2018.009670","volume":"73","author":"Y Oni","year":"2019","unstructured":"Oni Y, Song X, Schrader M, Kulshrestha A, Franck J, Asselta R, et al. Balancing container closure integrity and aesthetics for a robust aseptic or sterile vial packaging system. PDA J Pharm Sci Technol. 2019;73(6):572\u201387. https:\/\/doi.org\/10.5731\/PDAJPST.2018.009670.","journal-title":"PDA J Pharm Sci Technol"},{"key":"3315_CR70","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4236\/ajac.2024.1512025","volume":"15","author":"S Ramamoorthy","year":"1999","unstructured":"Ramamoorthy S, Chong NS, Kumar Hotha K. Strengthening extractable & leachable study submissions: best practices to avoid regulatory deficiencies. Am J Analyt Chem [Internet]. 1999;15:368\u201394. https:\/\/doi.org\/10.4236\/ajac.2024.1512025.","journal-title":"Am J Analyt Chem [Internet]"},{"key":"3315_CR71","unstructured":"Frances L. Parenteral Packaging Concerns | Contract Pharma [Internet]. [cited 2025 Sep 3]. https:\/\/www.contractpharma.com\/parenteral-packaging-concerns\/. Accessed 3 Sep 2025"},{"key":"3315_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS14102061","volume":"14","author":"MJ Rodr\u00edguez Fern\u00e1ndez","year":"2022","unstructured":"Rodr\u00edguez Fern\u00e1ndez MJ, Serrano Lopez DR, Torrado JJ. Effect of primary packaging material on the stability characteristics of diazepam and midazolam parenteral formulations. Pharmaceutics. 2022;14:2061. https:\/\/doi.org\/10.3390\/PHARMACEUTICS14102061.","journal-title":"Pharmaceutics"},{"key":"3315_CR73","unstructured":"Nicolas Tokhadz\u00e9, Meriem Sahnoune, Florent Goujon, Julien Dev\u00e9m, Philip Chennell, Alain Dequidt, et al. Insulin Adsorption onto PE and PVC Tubings [Internet]. ACS Appl Bio Mater. 2022 [cited 2025 Nov 7]. https:\/\/hal.science\/hal-03682647\/file\/pub3-v4.pdf. Accessed 7 Nov 2025"},{"key":"3315_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.yrtph.2016.08.011","volume":"81","author":"TH Broschard","year":"2016","unstructured":"Broschard TH, Glowienke S, Bruen US, Nagao LM, Teasdale A, Stults CLM, et al. Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics \u2013 current challenges and approaches. Regul Toxicol Pharmacol. 2016;81:201\u201311. https:\/\/doi.org\/10.1016\/j.yrtph.2016.08.011.","journal-title":"Regul Toxicol Pharmacol"},{"key":"3315_CR75","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16020264","author":"A Gosty\u0144ska","year":"2024","unstructured":"Gosty\u0144ska A, Przybylski T, Ogrodowczyk M. Y-site compatibility studies of parenteral nutrition and other intravenous medications in neonatal and pediatric patients: a review of the literature evidence. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16020264.","journal-title":"Pharmaceutics"},{"key":"3315_CR76","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009829","author":"CO Kim","year":"2018","unstructured":"Kim CO, Song J, Min JY, Park SJ, Lee HM, Byon HJ. A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: a preliminary study. Medicine (Baltimore). 2018. https:\/\/doi.org\/10.1097\/MD.0000000000009829.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"3315_CR77","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/S41783-023-00157-8","volume":"7","author":"N Sharma","year":"2023","unstructured":"Sharma N, Brahmankar Y, Babar D, Bhogle T, Mirase R, Rathod R, et al. Systematic approaches on extractable and leachable study designs in pharmaceuticals and medical devices: a review. J Packag Technol Res. 2023;7(3):127\u201345. https:\/\/doi.org\/10.1007\/S41783-023-00157-8.","journal-title":"J Packag Technol Res"},{"key":"3315_CR78","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16050572\/S1","volume":"16","author":"L Otero-Mill\u00e1n","year":"2024","unstructured":"Otero-Mill\u00e1n L, Bea-Mascato B, Legido Soto JL, Mart\u00ednez-L\u00f3pez-De-Castro N, Lago-Rivero N, Multidisciplinary Digital Publishing Institute (MDPI). Physicochemical stability of hospital parenteral nutrition solutions: effect of changes in composition and storage protocol. Pharmaceutics [Internet]. 2024;16. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16050572\/S1.","journal-title":"Pharmaceutics [Internet]"},{"key":"3315_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-019-46987-Y","author":"D Watrobska-Swietlikowska","year":"2019","unstructured":"Watrobska-Swietlikowska D. Compatibility of maximum inorganic and organic calcium and phosphate content in neonatal parenteral solutions. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/S41598-019-46987-Y.","journal-title":"Sci Rep"},{"key":"3315_CR80","unstructured":"Sonia Driss Chaieb, Souad Sfar, Jean- Claude Chaumeil. [Calcium and phosphates compatibilities in parenteral nutrition admixtures] - PubMed [Internet]. 2006 [cited 2025 Nov 7]. https:\/\/pubmed.ncbi.nlm.nih.gov\/17294890\/. Accessed 7 Nov 2025"},{"key":"3315_CR81","unstructured":"Maillard reactions in pharmaceutical formulations and human health - PubMed [Internet]. [cited 2025 Aug 18]. https:\/\/pubmed.ncbi.nlm.nih.gov\/23696045\/. Accessed 18 Aug 2025"},{"key":"3315_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/FOODS14111881","author":"L El Hosry","year":"2025","unstructured":"El Hosry L, Elias V, Chamoun V, Halawi M, Cayot P, Nehme A, et al. Maillard reaction: mechanism, influencing parameters, advantages, disadvantages, and food industrial applications: a review. Foods. 2025. https:\/\/doi.org\/10.3390\/FOODS14111881.","journal-title":"Foods"},{"key":"3315_CR83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/0148607109338216","volume":"34","author":"J Joy","year":"2010","unstructured":"Joy J, Silvestri AP, Franke R, Bistrian BR, Nehne J, Newton DW, et al. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration. J Parenter Enteral Nutr. 2010;34:46\u201354. https:\/\/doi.org\/10.1177\/0148607109338216.","journal-title":"J Parenter Enteral Nutr"},{"key":"3315_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/NU15163597","author":"H Romanowska","year":"2023","unstructured":"Romanowska H, Bartoszewicz K, Danko M, Wielopolska J, Popi\u0144ska K, \u017bydak J, et al. Unexpected serum and urine aluminum concentrations in pediatric patients on home parenteral nutrition. Nutrients. 2023. https:\/\/doi.org\/10.3390\/NU15163597.","journal-title":"Nutrients"},{"key":"3315_CR85","doi-asserted-by":"publisher","DOI":"10.3390\/NU16193230","author":"K Kitala-Ta\u0144ska","year":"2024","unstructured":"Kitala-Ta\u0144ska K, Han\u0107 A, Ju\u015bkiewicz J, Majewski M. Prolonged copper supplementation modified minerals in the kidney, liver and blood, and potentiated oxidative stress and vasodilation of isolated aortic rings in young Wistar rats. Nutrients. 2024. https:\/\/doi.org\/10.3390\/NU16193230.","journal-title":"Nutrients"},{"key":"3315_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/NU14091770","author":"P Perks","year":"2022","unstructured":"Perks P, Huynh E, Kaluza K, Boullata JI. Advances in trace element supplementation for parenteral nutrition. Nutrients. 2022. https:\/\/doi.org\/10.3390\/NU14091770.","journal-title":"Nutrients"},{"key":"3315_CR87","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1177\/0148607112464239","volume":"37","author":"L Bouchoud","year":"2013","unstructured":"Bouchoud L, Fonzo-Christe C, Klingm\u00fcller M, Bonnabry P. Compatibility of intravenous medications with parenteral nutrition: in vitro evaluation. J Parenter Enteral Nutr. 2013;37:416\u201324. https:\/\/doi.org\/10.1177\/0148607112464239.","journal-title":"J Parenter Enteral Nutr"},{"issue":"5","key":"3315_CR88","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1054\/clnu.2000.0109","volume":"19","author":"MC Allwood","year":"2000","unstructured":"Allwood MC, Martin HJ, Churchill Livingstone. The photodegradation of vitamins A and E in parenteral nutrition mixtures during infusion. Clin Nutr. 2000;19(5):339\u201342. https:\/\/doi.org\/10.1054\/clnu.2000.0109.","journal-title":"Clin Nutr"},{"key":"3315_CR89","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1016\/J.CLNME.2014.01.001","volume":"9","author":"TI Ferguson","year":"2014","unstructured":"Ferguson TI, Emery S, Price-Davies R, Cosslett AG, Elsevier. A review of stability issues associated with vitamins in parenteral nutrition. ESPEN J [Internet]. 2014;9:e49-53. https:\/\/doi.org\/10.1016\/J.CLNME.2014.01.001.","journal-title":"ESPEN J [Internet]"},{"issue":"5","key":"3315_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/NU17050846","volume":"17","author":"\u017b Sobol","year":"2025","unstructured":"Sobol \u017b, Chiczewski R, W\u0105tr\u00f3bska-\u015awietlikowska D, Multidisciplinary Digital Publishing Institute (MDPI). The modern approach to total parenteral nutrition: multidirectional therapy perspectives with a focus on the physicochemical stability of the lipid fraction. Nutrients. 2025;17(5). https:\/\/doi.org\/10.3390\/NU17050846.","journal-title":"Nutrients"},{"key":"3315_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/JPEN.2267","volume":"46","author":"C Compher","year":"2022","unstructured":"Compher C, Bingham AL, McCall M, Patel J, Rice TW, Braunschweig C, et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the American Society for Parenteral and Enteral Nutrition. J Parenter Enteral Nutr. 2022;46:12\u201341. https:\/\/doi.org\/10.1002\/JPEN.2267.","journal-title":"J Parenter Enteral Nutr"},{"key":"3315_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/S40942-021-00338-0","volume":"7","author":"GB Melo","year":"2021","unstructured":"Melo GB, Shoenfeld Y, Rodrigues EB. The risks behind the widespread use of siliconized syringes in the healthcare practice. Int J Retina Vitreous. 2021;7. https:\/\/doi.org\/10.1186\/S40942-021-00338-0.","journal-title":"Int J Retina Vitreous"},{"key":"3315_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0257873","volume":"16","author":"SC Chiang","year":"2021","unstructured":"Chiang SC, Shen M, Lin CC, Chang HP. Establishing a protocol for the compatibilities of closed-system transfer devices with multiple chemotherapy drugs under simulated clinical conditions. PLoS One. 2021;16. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0257873.","journal-title":"PLoS One"},{"issue":"1","key":"3315_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS13010021","volume":"13","author":"AK Koller","year":"2020","unstructured":"Koller AK, Krebs S, D\u00f6rje F. Medication safety in intravenous therapy: a compatibility study of clonidine with drugs frequently used in intensive care. Pharmaceutics. 2020;13(1). https:\/\/doi.org\/10.3390\/PHARMACEUTICS13010021.","journal-title":"Pharmaceutics"},{"key":"3315_CR95","doi-asserted-by":"publisher","unstructured":"De Pourcq JT, Riera A, Gras L, Garin N, Busquets MA, Cardenete J, et al. Physicochemical Compatibility of Ceftolozane-Tazobactam with Parenteral Nutrition. Pharmaceuticals [Internet]. Multidisciplinary Digital Publishing Institute (MDPI); 2024 [cited 2025 Nov 5];17:896. https:\/\/doi.org\/10.3390\/PH17070896\/S1","DOI":"10.3390\/PH17070896\/S1"},{"key":"3315_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS8040268","volume":"8","author":"M Stawny","year":"2019","unstructured":"Stawny M, Gosty\u0144ska A, Dettlaff K, Jeli\u0144ska A, Ko\u015bcielniak M, Ogrodowczyk M, et al. Development, validation, and stability assessment application of RP-HPLC-DAD method for quantification of ampicillin in total parenteral nutrition admixtures. Antibiotics (Basel). 2019;8:268. https:\/\/doi.org\/10.3390\/ANTIBIOTICS8040268.","journal-title":"Antibiotics (Basel)"},{"key":"3315_CR97","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.eimce.2022.07.010","volume":"41","author":"S Gim\u00e9nez-Giner","year":"2023","unstructured":"Gim\u00e9nez-Giner S, Llopis-Alemany A, Porta-Oltra B, Llopis-Salvia P, Climente-Mart\u00ed M, Mart\u00ednez-G\u00f3mez MA, Elsevier BV. Chemical stability and physical compatibility of meropenem in admixtures for continuous and extended intravenous infusions. Enfermedades infecciosas y microbiologia clinica (English ed). 2023;41:612\u20136. https:\/\/doi.org\/10.1016\/j.eimce.2022.07.010.","journal-title":"Enfermedades infecciosas y microbiologia clinica (English ed)"},{"issue":"3","key":"3315_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/PR9030453","volume":"9","author":"S Tomczak","year":"2021","unstructured":"Tomczak S, Radwan V, Jeli\u0144ska A, Stawny M. Application of the HPLC method in parenteral nutrition assessment: stability studies of ondansetron. Processes. 2021;9(3). https:\/\/doi.org\/10.3390\/PR9030453.","journal-title":"Processes"},{"key":"3315_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/EJHPHARM-2024-004358","volume":"0","author":"F Chen","year":"2025","unstructured":"Chen F, Ding H, Liu S, Chen Z, Tang L, Tong T. Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration. European Journal of Hospital Pharmacy [Internet]. 2025;0:1\u20135. https:\/\/doi.org\/10.1136\/EJHPHARM-2024-004358.","journal-title":"European Journal of Hospital Pharmacy [Internet]"},{"issue":"5","key":"3315_CR100","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/00185787241247133","volume":"59","author":"S Clemente Bautista","year":"2024","unstructured":"Clemente Bautista S, Jim\u00e9nez Lozano I, Castellote Belles L, Parram\u00f3n-Teixid\u00f3 CJ, Garcia Esquerda C, Puertas Sanjuan A, et al. Physical compatibility between intravenous magnesium sulfate and potassium or sodium phosphate in a pediatric intensive care unit. Hosp Pharm. 2024;59(5):557\u201361. https:\/\/doi.org\/10.1177\/00185787241247133.","journal-title":"Hosp Pharm"},{"key":"3315_CR101","doi-asserted-by":"publisher","first-page":"35","DOI":"10.9790\/0853-1801113541","volume":"18","author":"S Chandrababu","year":"2019","unstructured":"Chandrababu S, Parveen S, Bhargavi K, Devasree S. Evaluation of intravenous admixtures in MICU & general medicine department of South Indian tertiary care teaching hospital. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN [Internet]. 2019;18:35\u201341. https:\/\/doi.org\/10.9790\/0853-1801113541.","journal-title":"IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN [Internet]"},{"key":"3315_CR102","unstructured":"Health Canada. Becton-Dickinson - Disposable Syringes and Reduced Drug Potency Issues - Recalls and safety alerts [Internet]. 2015 [cited 2025 Sep 2]. https:\/\/healthycanadians.gc.ca\/recall-alert-rappel-avis\/hc-sc\/2015\/55044a-eng.php?TB_iframe=true&caption=Healthy+Canadians+-Recalls+and+Safety+Alerts+-+MedEffect+Canada+-+For+Health+Professionals&height=650&keepThis=true&width=850. Accessed 2 Sep 2025"},{"key":"3315_CR103","unstructured":"Health Canada. Baxter Intravenous Solution Bags \u2013 Potential Leak During Spiking of Administration Port - Canada.ca [Internet]. 2023 [cited 2025 Sep 2]. https:\/\/recalls-rappels.canada.ca\/en\/alert-recall\/baxter-intravenous-solution-bags-potential-leak-during-spiking-administration-port. Accessed 2 Sep 2025"},{"key":"3315_CR104","unstructured":"U.S. Food and Drug Administration. Baxter Initiates Voluntary Recall of Two Lots of IV Solutions due to Potential Presence of Particulate Matter | FDA [Internet]. 2018 [cited 2025 Sep 2]. https:\/\/www.fda.gov\/safety\/recalls-market-withdrawals-safety-alerts\/baxter-initiates-voluntary-recall-two-lots-iv-solutions-due-potential-presence-particulate-matter. Accessed 2 Sep 2025"},{"key":"3315_CR105","unstructured":"Summary of Recent Findings Related to Glass Delamination | FDA [Internet]. [cited 2025 Sep 26]. https:\/\/www.fda.gov\/drugs\/pharmaceutical-quality-resources\/summary-recent-findings-related-glass-delamination. Accessed 26 Sep 2025"},{"key":"3315_CR106","doi-asserted-by":"publisher","unstructured":"SCENIHR. THE SAFETY OF MEDICAL DEVICES CONTAINING DEHP-. 2016 [cited 2025 Sep 2]; https:\/\/doi.org\/10.2772\/45179","DOI":"10.2772\/45179"},{"key":"3315_CR107","unstructured":"Quality: packaging | European Medicines Agency (EMA) [Internet]. [cited 2025 Sep 11]. https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/research-and-development\/scientific-guidelines\/quality-guidelines\/quality-packaging. Accessed 11 Sep 2025"},{"key":"3315_CR108","unstructured":"COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) GUIDELINE ON PLASTIC IMMEDIATE PACKAGING MATERIALS ADOPTION BY CPMP\/CVMP FOR RELEASE FOR CONSULTATION. 2003 [cited 2025 Sep 12]; http:\/\/www.emea.eu.int. Accessed 12 Sep 2025"},{"key":"3315_CR109","unstructured":"EMA. ICH Q3E Extractables and leachables - scientific guideline | European Medicines Agency (EMA) [Internet]. [cited 2025 Sep 2]. https:\/\/www.ema.europa.eu\/en\/ich-q3e-extractables-leachables-scientific-guideline. Accessed 2 Sep 2025"},{"key":"3315_CR110","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS15071916","author":"LK Vora","year":"2023","unstructured":"Vora LK, Gholap AD, Jetha K, Thakur RRS, Solanki HK, Chavda VP. Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/PHARMACEUTICS15071916.","journal-title":"Pharmaceutics"},{"key":"3315_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS16101328","author":"DR Serrano","year":"2024","unstructured":"Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/PHARMACEUTICS16101328.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3315_CR112","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5731\/PDAJPST.2025.25206","volume":"79","author":"L Gil","year":"2025","unstructured":"Gil L, Basciano C, McGrath S, Singer J. Application of modeling as a tool for early derisking of parenteral delivery, from the primary container to the tissue. PDA J Pharm Sci Technol. 2025;79(2):246\u20137. https:\/\/doi.org\/10.5731\/PDAJPST.2025.25206.","journal-title":"PDA J Pharm Sci Technol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03315-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03315-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:05:13Z","timestamp":1770314713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03315-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03315-0","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"70"}}